Eargo IncNASDAQ:EAR
- LAST PRICE12.3100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots11.8800/ 1
- Ask / Lots12.4000/ 2
- Open / Previous Close0.0000 / 12.3100
- Day Range---
- 52 Week Range
- Volume580
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Time | Volume | EAR |
|---|
Yesterday
Eargo Regains Compliance With Nasdaq's Minimum Bid Price Requirement, from 3:43AM ET on Tuesday Feb 07, 2023 by MT Newswires
3:43AM ET on Tuesday Feb 07, 2023 by MT Newswires
Feb 6, 2023
BRIEF-Nasdaq Confirms Eargo’s Minimum Bid Price Deficiency Is Cured, from 4:03PM ET on Monday Feb 06, 2023 by Thomson Reuters
4:03PM ET on Monday Feb 06, 2023 by Thomson ReutersNasdaq Confirms Eargo's Minimum Bid Price Deficiency is Cured, from 4:01PM ET on Monday Feb 06, 2023 by GlobeNewswire
4:01PM ET on Monday Feb 06, 2023 by GlobeNewswire
Jan 17, 2023
BRIEF-Eargo Effects 1-For-20 Reverse Stock Split, from 4:15PM ET on Tuesday Jan 17, 2023 by Thomson Reuters
4:15PM ET on Tuesday Jan 17, 2023 by Thomson ReutersEargo Effects 1-for-20 Reverse Stock Split, from 4:01PM ET on Tuesday Jan 17, 2023 by GlobeNewswire
4:01PM ET on Tuesday Jan 17, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Eargo Inc | 255.1M | -0.2x | --- |
Neuronetics Inc | 165.0M | -4.4x | --- |
Berkeley Lights Inc | 155.0M | -1.8x | --- |
908 Devices Inc. | 330.1M | -11.9x | --- |
Cytosorbents Corp | 170.6M | -4.1x | --- |
Stereotaxis Inc | 184.9M | -10.0x | --- |
Company Information
Eargo, Inc. is a medical device company. The Company is engaged in developing products to improve the quality of life of people with hearing loss. Its Eargo hearing aids are virtually invisible, rechargeable, completely in-the-canal devices indicated to compensate for mild to moderate hearing loss. Its in-the-canal devices feature quality audio, which are designed to provide up to 16 hours of battery life and feature its soft flexible medical-grade silicon tips. It is marketing four versions of its hearing aids, the Eargo Max, the Eargo Neo HiFi, Eargo 5, and Eargo 6. In addition, Eargo hearing aids allow its users to cycle through four sound profiles, which include features, such as amplification and noise levels while on-the-go to accommodate different ambient noise environments. All products other than Eargo Max also offer customers a companion mobile application that helps them easily personalize their Eargo hearing aids to fit their needs and allows for remote updates.
Contact Information
- Headquarters
- 2665 North First Street, Suite 300SAN JOSE, CA, United States 95134
- Phone
- 650-351-7700
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Donald Spence
- President, Chief Executive Officer, Director
- Christian Gormsen
- Chief Financial Officer
- Adam Laponis
- Chief Operating Officer
- William Brownie
- Chief Accounting Officer and Principal Accounting Officer
- Mark Thorpe
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $255.1M |
|---|---|
Revenue (TTM) | $34.4M |
Shares Outstanding | 20.7M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-80.92 |
Book Value | $35.19 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -389.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
